227 related articles for article (PubMed ID: 19238910)
1. [MPO-positive cells and extracellular MPO in the glomeruli of MPO-ANCA-associated glomerulonephritis].
Kawashima S; Arimura Y; Nakabayashi K; Yamada A
Nihon Jinzo Gakkai Shi; 2009; 51(1):56-67. PubMed ID: 19238910
[TBL] [Abstract][Full Text] [Related]
2. Immunopathologic co-localization of MPO, IgG, and C3 in glomeruli in human MPO-ANCA-associated glomerulonephritis.
Kawashima S; Arimura Y; Sano K; Kudo A; Komagata Y; Kaname S; Kawakami H; Yamada A
Clin Nephrol; 2013 Apr; 79(4):292-301. PubMed ID: 23537682
[TBL] [Abstract][Full Text] [Related]
3. Myeloperoxidase (MPO)-specific CD4+ T cells contribute to MPO-anti-neutrophil cytoplasmic antibody (ANCA) associated glomerulonephritis.
Gan PY; Holdsworth SR; Kitching AR; Ooi JD
Cell Immunol; 2013 Mar; 282(1):21-7. PubMed ID: 23665205
[TBL] [Abstract][Full Text] [Related]
4. Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis.
Ruth AJ; Kitching AR; Kwan RY; Odobasic D; Ooi JD; Timoshanko JR; Hickey MJ; Holdsworth SR
J Am Soc Nephrol; 2006 Jul; 17(7):1940-9. PubMed ID: 16769746
[TBL] [Abstract][Full Text] [Related]
5. Expression of macrophage migration inhibitory factor in patients with myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
Taniguchi Y; Yorioka N; Yamashita K; Masaki T; Yamakido M
Clin Nephrol; 2000 Aug; 54(2):147-50. PubMed ID: 10968692
[TBL] [Abstract][Full Text] [Related]
6. Direct activation of glomerular endothelial cells by anti-moesin activity of anti-myeloperoxidase antibody.
Nagao T; Suzuki K; Utsunomiya K; Matsumura M; Saiga K; Wang PC; Minamitani H; Aratani Y; Nakayama T; Suzuki K
Nephrol Dial Transplant; 2011 Sep; 26(9):2752-60. PubMed ID: 21378392
[TBL] [Abstract][Full Text] [Related]
7. MPO-ANCA-positive anti-glomerular basement membrane antibody disease successfully treated by plasma exchange and immunosuppressive therapy.
Murakami T; Nagai K; Matsuura M; Kondo N; Kishi S; Araoka T; Kishi F; Sakiyama T; Mima A; Bando Y; Abe H; Doi T
Ren Fail; 2011; 33(6):626-31. PubMed ID: 21599422
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological study of myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
Yorioka N; Taniguchi Y; Amimoto D; Ogata S; Sakikubo E; Yamakido M; Naito T; Shimamoto F
Clin Nephrol; 1999 Nov; 52(5):293-6. PubMed ID: 10584992
[TBL] [Abstract][Full Text] [Related]
9. Renal expression of matrix metalloproteinases in human ANCA-associated glomerulonephritis.
Sanders JS; van Goor H; Hanemaaijer R; Kallenberg CG; Stegeman CA
Nephrol Dial Transplant; 2004 Jun; 19(6):1412-9. PubMed ID: 15034162
[TBL] [Abstract][Full Text] [Related]
10. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
Rutgers A; Slot M; van Paassen P; van Breda Vriesman P; Heeringa P; Tervaert JW
Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043
[TBL] [Abstract][Full Text] [Related]
11. [A case of progressive systemic sclerosis with crescentic glomerulonephritis associated with myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) and anti-glomerular basement membrane antibody (anti-GBM Ab)].
Kobayashi M; Saito M; Minoshima S; Arimura Y; Nagasawa T
Nihon Jinzo Gakkai Shi; 1995 Mar; 37(3):207-11. PubMed ID: 7731110
[TBL] [Abstract][Full Text] [Related]
12. [Rapid-detection GBM-ANCA ELISA. An emergency tool for the early diagnosis of type I and II rapidly progressive glomerulonephritis].
Arranz O; Ara J; Rodríguez R; Poveda R; Serra A; Solé-Amigó J; Fort J; Mirapeix E; Darnell A
Nefrologia; 2001; 21(4):349-54. PubMed ID: 11816510
[TBL] [Abstract][Full Text] [Related]
13. Glomerular lesions in patients with Churg-Strauss syndrome and the anti-myeloperoxidase antibody.
Kikuchi Y; Ikehata N; Tajima O; Yoshizawa N; Miura S
Clin Nephrol; 2001 Jun; 55(6):429-35. PubMed ID: 11434353
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies.
Schreiber A; Xiao H; Falk RJ; Jennette JC
J Am Soc Nephrol; 2006 Dec; 17(12):3355-64. PubMed ID: 17108314
[TBL] [Abstract][Full Text] [Related]
15. Renal participation of myeloperoxidase in antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis.
O'Sullivan KM; Lo CY; Summers SA; Elgass KD; McMillan PJ; Longano A; Ford SL; Gan PY; Kerr PG; Kitching AR; Holdsworth SR
Kidney Int; 2015 Nov; 88(5):1030-46. PubMed ID: 26176828
[TBL] [Abstract][Full Text] [Related]
16. [A case of necrotizing crescentic glomerulonephritis in which myeloperoxidase antineutrophil cytoplasmic antibodies (ANCA) reflect the disease activity and recognize various neutrophil cytoplasmic constituents].
Fujimoto T; Kimura A; Ameno M; Shiiki H; Dohi K
Nihon Jinzo Gakkai Shi; 1997 Mar; 39(2):172-7. PubMed ID: 9134836
[TBL] [Abstract][Full Text] [Related]
17. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.
Vizjak A; Rott T; Koselj-Kajtna M; Rozman B; Kaplan-Pavlovcic S; Ferluga D
Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976
[TBL] [Abstract][Full Text] [Related]
18. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO
Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931
[TBL] [Abstract][Full Text] [Related]
19. Epitope analysis of myeloperoxidase (MPO) specific anti-neutrophil cytoplasmic autoantibodies (ANCA) in MPO-ANCA-associated glomerulonephritis.
Fujii A; Tomizawa K; Arimura Y; Nagasawa T; Ohashi YY; Hiyama T; Mizuno S; Suzuki K
Clin Nephrol; 2000 Apr; 53(4):242-52. PubMed ID: 10809410
[TBL] [Abstract][Full Text] [Related]
20. [Case of rapidly progressive glomerulonephritis with anti-glomerular basement membrane antibody in the course of MPO-ANCA-associated pachymeningitis].
Yamazaki C; Arai S; Tamura Y; Suzuki Y; Nakajima H; Kojima K; Uchida S
Nihon Jinzo Gakkai Shi; 2009; 51(4):490-5. PubMed ID: 19601559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
